Bedside Endoscopic Ultrasound in Critically Ill patients

Abstract EN

Background.

The aim of this study was to evaluate the role and impact of EUS in the management of critically ill patients.

Methods.

We retrospectively identified all patients at our institution over a 68-month period in whom bedside inpatient EUS was performed.

EUS was considered to have a significant impact if a new diagnosis was established and/or the findings altered subsequent clinical management.

Results.

Fifteen patients (9 male; mean age 58±15 years) underwent bedside EUS without complications.

EUS-FNA (median 4 passes; range 2–7) performed in 12 (80%) demonstrated a malignant mediastinal mass/lymph node (5), pancreatic abscess (1), excluded a pelvic abscess (1), established enlarged gastric folds as benign (1) and excluded malignancy in enlarged mediastinal (1) and porta hepatis adenopathy (1).

In two patients, EUS-FNA failed to diagnose mediastinal histoplasmosis (1) and a hemorrhagic pancreatic pseudocyst (1).

In three diagnostic exams without FNA, EUS correctly excluded choledocholithaisis (n=1) and cholangiocarcinoma (1), and found gastric varices successfully thrombosed after previous cyanoacrylate injection (1).

EUS was considered to have an impact in 13/15 (87%) patients.

Conclusions.

In this series, bedside EUS in critically ill patients was technically feasible, safe and had a major impact on the majority of patients.